Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reactive oxygen species (ROS) pathway refers to the network of biochemical processes involving the generation, regulation, and signaling functions of ROS within biological systems. ROS are produced as natural byproducts of cellular metabolism and play dual roles: at physiological levels, they act as signaling molecules; at excessive levels, they cause oxidative stress and cellular damage. Key components include superoxide, hydrogen peroxide, and hydroxyl radical. Regulators include NADPH oxidases and mitochondrial respiratory chain complexes. The pathway influences processes such as cell proliferation, differentiation, apoptosis, and immune response and is implicated in diseases such as cardiovascular disease, neurodegeneration, and cancer. Therapeutic strategies involve modulating ROS production or scavenging ROS.
Modulation of ROS production, scavenging of ROS, or targeting downstream signaling molecules.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive Oxygen Species Pathway.